3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 1
1
Status
Recruiting
6
Terminated
2
Not yet recruiting
2
Suspended
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
1
Bites and Stings
1
Interventions
pembrolizumab
28
Carboplatin
18
Cisplatin
15
Nivolumab
13
Pemetrexed
12
Paclitaxel
11
Specimen Handling
10
Ipilimumab
10
Gemcitabine
10
venetoclax
8
durvalumab
8
atezolizumab
8
Radiotherapy
8
Radiosurgery
8
Magnetic Resonance Spectroscopy
8
Docetaxel
7
Cyclophosphamide
7
Biopsy
7
fludarabine
6
enzalutamide
6
Bevacizumab
6
tislelizumab
5
tazemetostat
5
X-Rays
5
Trastuzumab
5
Surveys and Questionnaires
5
Practice Guidelines as Topic
5
Interviews as Topic
5
Injections
5
Dexamethasone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Hydroxyurea
×
90 days
×
Clear all
NCT05853458
2026-04-30
HU-F-AIM
Novartis
Phase 4
Terminated
76 enrolled
NCT06063317
2026-03-06
OASIS
Imugene Limited
Phase 1
Terminated
25 enrolled